サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434355

抗真菌薬市場：感染タイプ、剤型、治療適応症別-2024-2030年の世界予測

Antifungal Drugs Market by Infection Type (Superficial Fungal Infection, Systemic Fungal infection), Type (Allylamines, Azoles, Echinocandins), Form, Therapeutic Indications - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗真菌薬市場：感染タイプ、剤型、治療適応症別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗真菌薬市場規模は2023年に148億9,000万米ドルと推計され、2024年には158億米ドルに達し、CAGR 6.19%で2030年には226億9,000万米ドルに達すると予測されます。

抗真菌薬の世界市場

主な市場の統計
基準年[2023］ 148億9,000万米ドル
予測年[2024] 158億米ドル
予測年 [2030] 226億9,000万米ドル
CAGR（%） 6.19%
抗真菌薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは抗真菌薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、抗真菌薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-抗真菌薬市場の市場規模および予測は？

2-抗真菌薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-抗真菌薬市場における技術動向と規制の枠組みは？

4-抗真菌薬市場における主要ベンダーの市場シェアは？

5-抗真菌薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中の人口における真菌感染症の有病率の増加
      • 無数の真菌感染症に対する高い意識レベル
      • 抗真菌薬に対する政府の好意的な承認
    • 抑制要因
      • 従来の抗真菌薬を引き続き優先
    • 機会
      • 研究開発資金を増額し、製品イノベーションに注力
      • 抗真菌薬に関する国家的提携とパートナーシップ
    • 課題
      • 偽造医薬品の存在とブランド医薬品の特許切れ
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 抗真菌薬市場感染症の種類別

  • 表在性真菌感染症
  • 全身性真菌感染症

第7章 抗真菌薬市場：タイプ別

  • アリルアミン
    • ブテナフィン
    • ナフティフィン
    • テルビナフィン
  • アゾール
    • イミダゾール
    • チアゾール
    • ボリカナゾール
  • エキノカンジン
    • アニデュラファンギン
    • カスポファンギン
    • ミカファンギン
  • ポリエン
    • アムホテリシンB
    • カンディシジン
    • ハマイシン
    • ナタマイシン

第8章 抗真菌薬市場：形態別

  • 軟膏
  • 粉
  • タブレット

第9章 抗真菌薬市場治療適応別

  • アスペルギルス症
  • カンジダ症
  • 皮膚糸状菌症

第10章 南北アメリカの抗真菌薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の抗真菌薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの抗真菌薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Astellas Pharma Inc.
    • Bayer HealthCare Pharmaceuticals LLC
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Cadila Pharmaceuticals Limited
    • Cardinal Health, Inc.
    • Cipla, Inc.
    • Enzon Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Gilead Sciences, Inc.
    • Hologic, Inc.
    • Johnson & Johnson
    • Lakewood-Amedex, Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer, Inc.
    • Quest Diagnostics Incorporated
    • SCYNEXIS, Inc.
    • Sigma-Aldrich, Inc.
    • Sun Pharmaceutical Industries Ltd.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANTIFUNGAL DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIFUNGAL DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTIFUNGAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIFUNGAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTIFUNGAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIFUNGAL DRUGS MARKET DYNAMICS
  • FIGURE 7. ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 12. ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2023 VS 2030 (%)
  • FIGURE 14. ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ANTIFUNGAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ANTIFUNGAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTIFUNGAL DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTIFUNGAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIFUNGAL DRUGS MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIFUNGAL DRUGS MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIFUNGAL DRUGS MARKET SIZE, BY BUTENAFINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIFUNGAL DRUGS MARKET SIZE, BY NAFTIFINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIFUNGAL DRUGS MARKET SIZE, BY TERBINAFINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIFUNGAL DRUGS MARKET SIZE, BY IMIDAZOLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIFUNGAL DRUGS MARKET SIZE, BY THIAZOLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIFUNGAL DRUGS MARKET SIZE, BY VORICANAZOLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 21. ANTIFUNGAL DRUGS MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANTIFUNGAL DRUGS MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANTIFUNGAL DRUGS MARKET SIZE, BY MICAFUNGIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 26. ANTIFUNGAL DRUGS MARKET SIZE, BY AMPHOTERICIN B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ANTIFUNGAL DRUGS MARKET SIZE, BY CANDICIDIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ANTIFUNGAL DRUGS MARKET SIZE, BY HAMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ANTIFUNGAL DRUGS MARKET SIZE, BY NATAMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. ANTIFUNGAL DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. ANTIFUNGAL DRUGS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. ANTIFUNGAL DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 35. ANTIFUNGAL DRUGS MARKET SIZE, BY ASPERGILLOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. ANTIFUNGAL DRUGS MARKET SIZE, BY CANDIDIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. ANTIFUNGAL DRUGS MARKET SIZE, BY DERMATOPHYTOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 322. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 330. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 338. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 346. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 362. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 363. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 364. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
  • TABLE 366. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-
目次
Product Code: MRR-4312A385A46C

[192 Pages Report] The Antifungal Drugs Market size was estimated at USD 14.89 billion in 2023 and expected to reach USD 15.80 billion in 2024, at a CAGR 6.19% to reach USD 22.69 billion by 2030.

Global Antifungal Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 14.89 billion
Estimated Year [2024] USD 15.80 billion
Forecast Year [2030] USD 22.69 billion
CAGR (%) 6.19%
Antifungal Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antifungal Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antifungal Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antifungal Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Becton, Dickinson and Company, bioMerieux SA, Cadila Pharmaceuticals Limited, Cardinal Health, Inc., Cipla, Inc., Enzon Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Hologic, Inc., Johnson & Johnson, Lakewood-Amedex, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Quest Diagnostics Incorporated, SCYNEXIS, Inc., Sigma-Aldrich, Inc., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antifungal Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Infection Type
    • Superficial Fungal Infection
    • Systemic Fungal infection
  • Type
    • Allylamines
      • Butenafine
      • Naftifine
      • Terbinafine
    • Azoles
      • Imidazoles
      • Thiazoles
      • Voricanazole
    • Echinocandins
      • Anidulafungin
      • Caspofungin
      • Micafungin
    • Polyenes
      • Amphotericin B
      • Candicidin
      • Hamycin
      • Natamycin
  • Form
    • Ointments
    • Powder
    • Tablets
  • Therapeutic Indications
    • Aspergillosis
    • Candidiasis
    • Dermatophytosis
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antifungal Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antifungal Drugs Market?

3. What are the technology trends and regulatory frameworks in the Antifungal Drugs Market?

4. What is the market share of the leading vendors in the Antifungal Drugs Market?

5. Which modes and strategic moves are suitable for entering the Antifungal Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antifungal Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of fungal infection among population worldwide
      • 5.1.1.2. High awareness levels pertaining to myriad fungal infections
      • 5.1.1.3. Favorable government approvals for antifungal drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Continued preference for conventional antifungal drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased R&D funding and focus on product innovation
      • 5.1.3.2. Stategic alliances and partnerships for antifungal drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of counterfeit drugs and patent expiration of branded drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antifungal Drugs Market, by Infection Type

  • 6.1. Introduction
  • 6.2. Superficial Fungal Infection
  • 6.3. Systemic Fungal infection

7. Antifungal Drugs Market, by Type

  • 7.1. Introduction
  • 7.2. Allylamines
    • 7.3.1. Butenafine
    • 7.3.2. Naftifine
    • 7.3.3. Terbinafine
  • 7.3. Azoles
    • 7.4.1. Imidazoles
    • 7.4.2. Thiazoles
    • 7.4.3. Voricanazole
  • 7.4. Echinocandins
    • 7.5.1. Anidulafungin
    • 7.5.2. Caspofungin
    • 7.5.3. Micafungin
  • 7.5. Polyenes
    • 7.6.1. Amphotericin B
    • 7.6.2. Candicidin
    • 7.6.3. Hamycin
    • 7.6.4. Natamycin

8. Antifungal Drugs Market, by Form

  • 8.1. Introduction
  • 8.2. Ointments
  • 8.3. Powder
  • 8.4. Tablets

9. Antifungal Drugs Market, by Therapeutic Indications

  • 9.1. Introduction
  • 9.2. Aspergillosis
  • 9.3. Candidiasis
  • 9.4. Dermatophytosis

10. Americas Antifungal Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Antifungal Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Antifungal Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Astellas Pharma Inc.
    • 14.1.3. Bayer HealthCare Pharmaceuticals LLC
    • 14.1.4. Becton, Dickinson and Company
    • 14.1.5. bioMerieux SA
    • 14.1.6. Cadila Pharmaceuticals Limited
    • 14.1.7. Cardinal Health, Inc.
    • 14.1.8. Cipla, Inc.
    • 14.1.9. Enzon Pharmaceuticals, Inc.
    • 14.1.10. F. Hoffmann-La Roche Ltd.
    • 14.1.11. Gilead Sciences, Inc.
    • 14.1.12. Hologic, Inc.
    • 14.1.13. Johnson & Johnson
    • 14.1.14. Lakewood-Amedex, Inc.
    • 14.1.15. Merck KGaA
    • 14.1.16. Novartis AG
    • 14.1.17. Pfizer, Inc.
    • 14.1.18. Quest Diagnostics Incorporated
    • 14.1.19. SCYNEXIS, Inc.
    • 14.1.20. Sigma-Aldrich, Inc.
    • 14.1.21. Sun Pharmaceutical Industries Ltd.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing